Genitourinary cancers

Progress in Experimental Tumor Research

Volumn 40, Issue , 2008, Pages 92-101

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER TUMOR; FEMALE; HUMAN; KIDNEY TUMOR; MALE; PROSTATE TUMOR; RISK FACTOR; SECOND CANCER; TESTIS TUMOR; UROGENITAL TRACT TUMOR;

FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASMS, SECOND PRIMARY; PROSTATIC NEOPLASMS; RISK FACTORS; TESTICULAR NEOPLASMS; URINARY BLADDER NEOPLASMS; UROGENITAL NEOPLASMS;

EID: 52349115174     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000151877     Document Type: Article

References (49)

1. Beisland C, Talleraas O, Bakke A, et al: Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU Int 2006;97:698-702.
2. Rabbani F, Grimaldi G, Russo P: Multiple primary malignancies in renal cell carcinoma. J Urol 1998; 160:1255-1259.
3. McCredie M, Macfarlane GJ, Stewart J, et al: Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91. Cancer Causes Control 1996;7:337-344.
4. Czene K, Hemminki K: Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden. J Urol 2003;169: 1271-1275.
5. Thompson RH, Leibovich BC, Cheville JC, et al: Second primary malignancies associated with renal cell carcinoma histological subtypes. J Urol 2006;176: 900-903; discussion 903-904.
6. Barocas DA, Rabbani F, Scherr DS, et al: A population-based study of renal cell carcinoma and prostate cancer in the same patients. BJU Int 2006;97: 33-36.
7. Czene K, Hemminki K: Kidney cancer in the Swedish Family Cancer Database: familial risks and second primary malignancies. Kidney Int 2002;61:1806-1813.
8. Wagner JR, Linehan WM: Molecular genetics of renal cell carcinoma. Semin Urol Oncol 1996; 14: 244-249.
9. Kunthur A, Wiernik PH, Dutcher JP: Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature. Am J Hematol 2006;81:271-280.
10. Rabbani F, Russo P: Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma. Urology 1999;54:28-33.
11. Anderson CM, Pusztai L, Palmer JL, et al: Coincident renal cell carcinoma and non-Hodgkin's lymphoma: the M.D. Anderson experience and review of the literature. J Urol 1998;159:714-717.
12. Defined as the tissue in the kidneys that collects urine (the renal pelvis) and the ureters.
13. Rabbani F, Perrotti M, Russo P, et al: Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance. J Clin Oncol 2001;19:94-100.
14. Raman JD, Ng CK, Boorjian SA, et al: Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int 2005;96:1031-1035.
15. Kurokawa K, Ito K, Yamamoto T, et al: Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer. Urology 2004;63:268-272.
16. Kotake T, Kiyohara H: Multiple primary cancers (MPC) associated with bladder cancer: an analysis of the clinical and autopsy cases in Japan. Jpn J Clin Oncol 1985;15(suppl 1):201-210.
17. Kellen E, Zeegers MP, Dirx M, et al: Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, the Netherlands and the United Kingdom. Eur J Cancer 2007;43:1694-1700.
18. Fabbri C, Ravaioli A, Ravaioli A, et al: Risk of cancer of the prostate and of the kidney parenchyma following bladder cancer. Tumori 2007;93:124-128.
19. Kinoshita Y, Singh A, Rovito PM Jr, et al: Double primary cancers of the prostate and bladder: a literature review. Clin Prost Cancer 2004;3:83-86.
20. Salminen E, Pukkala E, Teppo L: Bladder cancer and the risk of smoking-related cancers during followup. J Urol 1994;152:1420-1423.
21. Klotz T, Hofstadter F, Gerken M: Interdisciplinary oncologic after-care exemplified by second primary tumors after bladder carcinoma. Urologe A 2003;42: 1485-1490.
22. Kleinerman RA, Liebermann JV, Li FP: Second cancer following cancer of the male genital system in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:139-147.
23. Levi F, Randimbison L, Te V, et al: Second primary tumors after prostate carcinoma. Cancer 1999;86: 1567-1570.
24. Thellenberg C, Maimer B, Tavelin B, et al: Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. J Urol 2003;169:1345-1348.
25. Goldstraw MA, Payne H, Kirby RS: What are the risks of second cancer formation after radiotherapy to the prostate? BJU Int 2006;98:489-491.
26. Singh A, Kinoshita Y, Rovito PM Jr, et al: Higher than expected association of clinical prostate and bladder cancers. J Urol 2005;173:1526-1529.
27. Boorjian S, Cowan JE, Konety BR, et al: Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologie Research Endeavor. J Urol 2007;177:883-887; discussion 887-888.
28. Brenner DJ, Curtis RE, Hall EJ, et al: Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000;88: 398-406.
29. Pickles T, Phillips N: The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. Radiother Oncol 2002;65:145-151.
30. Movsas B, Hanlon AL, Pinover W, et al: Is there an increased risk of second primaries following prostate irradiation? Int J Radiat Oncol Biol Phys 1998;41: 251-255.
31. Neugut AI, Ahsan H, Robinson E: Bladder carcinoma and other second malignancies after radio-therapy for prostate carcinoma. Cancer 1997:79: 1600-1604.
32. Chrouser K, Leibovich B, Bergstralh E, et al: Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 2005;174:107-110; discussion 110-111.
33. Baxter NN, Tepper JE, Durham SB, et al: Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 2005;128: 819-824.
34. Kendal WS, Eapen L, Macrae R, et al: Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer. Int J Radiat Oncol Biol Phys 2006;65:661-668.
35. Liauw SL, Sylvester JE, Morris CG, et al: Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 2006;66:669-673.
36. Moon K, Stukenborg GJ, Keim J, et al: Cancer incidence after localized therapy for prostate cancer. Cancer 2006;107:991-998.
37. Schneider U, Lomax A, Besserer J, et al: The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 2007;68:892-897.
38. Dong C, Lonnstedt I, Hemminki K: Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. Eur J Cancer 2001;37:1878-1885.
39. Nichols CR, Loehrer PJ Sr: The story of second cancers in patients cured of testicular cancer: tarnishing success or burnishing irrelevance? J Natl Cancer Inst 1997;89:1394-1395.
40. Fossa SD: Long-term sequelae after cancer therapy survivorship after treatment for testicular cancer. Acta Oncol 2004;43:134-141.
41. Chaudhary UB, Haldas JR: Long-term complications of chemotherapy for germ cell tumours. Drugs 2003;63:1565-1577.
42. Travis LB, Fossa SD, Schonfeld SJ, et al: Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005;97: 1354-1365.
43. After at least 10 years of follow-up.
44. Van den Belt-Dusebout AW, de Wit R, Gietema JA, et al: Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007;25:4370-4378.
45. Travis LB, Andersson M, Gospodarowicz M, et al: Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst 2000;92:1165-1171.
46. Kollmannsberger C, Hartmann JT, Kanz L, et al: Therapy-related malignancies following treatment of germ cell cancer. Int J Cancer 1999;83:860-863.
47. Robinson D, Moller H, Horwich A: Mortality and incidence of second cancers following treatment for testicular cancer. Br J Cancer 2007;96:529-533.
48. Schairer C, Hisada M, Chen BE, et al: Comparative mortality for 621 second cancers in 29,356 testicular cancer survivors and 12,420 matched first cancers. J Natl Cancer Inst 2007;99:1248-1256.
49. Richiardi L, Scelo G, Boffetta P, et al: Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries. Int J Cancer 2007;120:623-631.